siRNA therapy decreases triglycerides in patients with unusual problem

.STUDY HIGHLIGHT.19 September 2024.

Plozasiran reduced triglyceride amounts through 80% as well as decreased the danger of pancreatitis in people with consistent chylomicronemia, with or without a hereditary medical diagnosis.